Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 61, Issue 7, 2006, Pages 660-662

  Shibata, Nobuto ^a   Ohnuma, Tohru ^a   Higashi, Shinji ^a   Higashi, Maiko ^a   Usui, Chie ^a   Ohkubo, Taku ^a   Watanabe, Tomoko ^a   Kawashima, Ritsuko ^a   Kitajima, Akiyoshi ^a   Ueki, Akira ^b   Nagao, Masatsugu ^c   Arai, Heii ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Nagao Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33746594095     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/61.7.660     Document Type: Article

References (14)

1. Yanagisawa K. Cholesterol and pathological processes in Alzheimer's disease. J Neurosci Res. 2002;70:361-366.
2. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000;356:1627-1631.
3. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
4. Chen WG, West AE, Tao X, et al. Upstream stimulatory factors are mediators of Ca2+-responsive transcription in neurons. J Neurosci. 2003;23:2572-2581.
5. Steiger JL, Bandyopadhyay S, Farb DH, Russek SJ. cAMP response element-binding protein, activating transcription factor-4, and upstream stimulatory factor differentially control hippocampal GABABR1a and GABABR1b subunit gene expression through alternative promoters. J Neurosci. 2004;24:6115-6126.
6. Kovacs DM, Wasco W, Witherby J, et al. The upstream stimulatory factor functionally interacts with the Alzheimer amyloid beta-protein precursor gene. Hum Mol Genet. 1995;4:1527-1533.
7. Vostrov AA, Quitschke WW, Vidal F, Schwarzman AL, Goldgaber D. USF binds to the APB alpha sequence in the promoter of the amyloid beta-protein precursor gene. Nucleic Acids Res. 1995;23:2734-2741.
8. Tabuchi A, Sakaya H, Kisukeda T, Fushiki H, Tsuda M. Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem. 2002;277:35920-35931.
9. Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005;117:444-451.
10. Pajukanta P, Lilja HE, Sinsheimer JS, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36:371-376.
11. Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med. 2004;10:362-365.
12. Putt W, Palmen J, Nicaud V, et al. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet. 2004;13:1587-1597.
13. Hiltunen M, Mannermaa A, Thompson D, et al. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology. 2001;57:1663-1668.
14. Tan ZS, Seshadri S, Beiser A, et al. Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med. 2003;163:1053-1057.